Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy

by | Feb 27, 2017 | Uncategorized

Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]

Executive Relationship Marketing: The ‘Secret Sauce’ for any successful early-stage company

 Imagine what your company’s revenue would look like if you could arrange 10-15 meetings in 90 days with top C-Suite executives. This White Paper goes into depth on this sophisticated process.

Your White Paper is on its way!